BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32614525)

  • 1. The expression and regulation of HOX genes and membrane proteins among different cytogenetic groups of acute myeloid leukemia.
    Wang H; Lin SY; Hu FF; Guo AY; Hu H
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1365. PubMed ID: 32614525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the key genes and microRNAs in adult acute myeloid leukemia with FLT3 mutation by bioinformatics analysis.
    Chen S; Chen Y; Zhu Z; Tan H; Lu J; Qin P; Xu L
    Int J Med Sci; 2020; 17(9):1269-1280. PubMed ID: 32547322
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of circRNA-lncRNA-miRNA-mRNA Competitive Endogenous RNA Network as Novel Prognostic Markers for Acute Myeloid Leukemia.
    Cheng Y; Su Y; Wang S; Liu Y; Jin L; Wan Q; Liu Y; Li C; Sang X; Yang L; Liu C; Wang Z
    Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32751923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of the
    Chen SL; Qin ZY; Hu F; Wang Y; Dai YJ; Liang Y
    Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31426381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of pediatric acute myeloid leukemia based on miRNA expression profiles.
    Obulkasim A; Katsman-Kuipers JE; Verboon L; Sanders M; Touw I; Jongen-Lavrencic M; Pieters R; Klusmann JH; Michel Zwaan C; van den Heuvel-Eibrink MM; Fornerod M
    Oncotarget; 2017 May; 8(20):33078-33085. PubMed ID: 28380436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia.
    Qu X; Davison J; Du L; Storer B; Stirewalt DL; Heimfeld S; Estey E; Appelbaum FR; Fang M
    Epigenetics; 2015; 10(6):526-35. PubMed ID: 25996682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia.
    Musialik E; Bujko M; Kober P; Grygorowicz MA; Libura M; Przestrzelska M; Juszczyński P; Borg K; Florek I; Jakóbczyk M; Siedlecki JA
    Mol Med Rep; 2015 May; 11(5):3948-54. PubMed ID: 25585874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of specific microRNA and their targets in acute myeloid leukemia.
    Cammarata G; Augugliaro L; Salemi D; Agueli C; La Rosa M; Dagnino L; Civiletto G; Messana F; Marfia A; Bica MG; Cascio L; Floridia PM; Mineo AM; Russo M; Fabbiano F; Santoro A
    Am J Hematol; 2010 May; 85(5):331-9. PubMed ID: 20425795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia.
    Danen-van Oorschot AA; Kuipers JE; Arentsen-Peters S; Schotte D; de Haas V; Trka J; Baruchel A; Reinhardt D; Pieters R; Zwaan CM; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2012 May; 58(5):715-21. PubMed ID: 21818844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potential therapeutic target genes, key miRNAs and mechanisms in acute myeloid leukemia based on bioinformatics analysis.
    Zhao Y; Zhang X; Zhao Y; Kong D; Qin F; Sun J; Dong Y
    Med Oncol; 2015 May; 32(5):152. PubMed ID: 25832863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular dysfunctions in acute myeloid leukemia revealed by integrated analysis of microRNA and transcription factor.
    Lin XC; Xu Y; Sun GP; Wen JL; Li N; Zhang YM; Yang ZG; Zhang HT; Dai Y
    Int J Oncol; 2016 Jun; 48(6):2367-80. PubMed ID: 27082628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOX deregulation in acute myeloid leukemia.
    Rice KL; Licht JD
    J Clin Invest; 2007 Apr; 117(4):865-8. PubMed ID: 17404613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.
    Hollink IH; van den Heuvel-Eibrink MM; Arentsen-Peters ST; Pratcorona M; Abbas S; Kuipers JE; van Galen JF; Beverloo HB; Sonneveld E; Kaspers GJ; Trka J; Baruchel A; Zimmermann M; Creutzig U; Reinhardt D; Pieters R; Valk PJ; Zwaan CM
    Blood; 2011 Sep; 118(13):3645-56. PubMed ID: 21813447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homeobox gene expression in acute myeloid leukemia is linked to typical underlying molecular aberrations.
    Skvarova Kramarzova K; Fiser K; Mejstrikova E; Rejlova K; Zaliova M; Fornerod M; Drabkin HA; van den Heuvel-Eibrink MM; Stary J; Trka J; Starkova J
    J Hematol Oncol; 2014 Dec; 7():94. PubMed ID: 25539595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of miRNA-mRNA Network Associated with Acute Myeloid Leukemia Survival.
    Zhang C; Bai G; Zhu W; Bai D; Bi G
    Med Sci Monit; 2017 Oct; 23():4705-4714. PubMed ID: 28965123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HOXA/PBX3 knockdown impairs growth and sensitizes cytogenetically normal acute myeloid leukemia cells to chemotherapy.
    Dickson GJ; Liberante FG; Kettyle LM; O'Hagan KA; Finnegan DP; Bullinger L; Geerts D; McMullin MF; Lappin TR; Mills KI; Thompson A
    Haematologica; 2013 Aug; 98(8):1216-25. PubMed ID: 23539541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Key Genes and Pathways Associated with RUNX1 Mutations in Acute Myeloid Leukemia Using Bioinformatics Analysis.
    Zhu F; Huang R; Li J; Liao X; Huang Y; Lai Y
    Med Sci Monit; 2018 Oct; 24():7100-7108. PubMed ID: 30289875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Expression Profile of Patients with Acute Myeloid Leukemia in Response to Azacitidine with Biological System Approach.
    Hejab R; Rahimi H; Abedinlou H; Ghoraeian P
    Microrna; 2023; 12(3):233-242. PubMed ID: 37642007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Huang HH; Chen FY; Chou WC; Hou HA; Ko BS; Lin CT; Tang JL; Li CC; Yao M; Tsay W; Hsu SC; Wu SJ; Chen CY; Huang SY; Tseng MH; Tien HF; Chen RH
    BMC Cancer; 2019 Jun; 19(1):617. PubMed ID: 31234830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts.
    Wang J; Li F; Ma Z; Yu M; Guo Q; Huang J; Yu W; Wang Y; Jin J
    EBioMedicine; 2018 Feb; 28():90-96. PubMed ID: 29402726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.